Pathfinder
Editor, Senior Moderator
<TABLE cellSpacing=0 cellPadding=0 width="95%" align=center border=0><TBODY><TR><TD class=spacer_5px><TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD>As H1N1 spreads, vaccinations start
</TD></TR><TR><TD></TD></TR><TR><TD>Lee Ji-yoon
The Korea Herald
Publication Date: 28-10-2009
</TD></TR><TR><TD class=spacer_ver10px style38></TD></TR></TBODY></TABLE></TD></TR><TR><TD class=bg_dotted01></TD></TR><TR><TD class=spacer_5px>
</TD></TR></TBODY></TABLE>
http://www.asianewsnet.net/news.php?id=8415&sec=14
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
</TD></TR><TR><TD></TD></TR><TR><TD>Lee Ji-yoon
The Korea Herald
Publication Date: 28-10-2009
</TD></TR><TR><TD class=spacer_ver10px style38></TD></TR></TBODY></TABLE></TD></TR><TR><TD class=bg_dotted01></TD></TR><TR><TD class=spacer_5px>
Amid a recent surge in patients infected with the H1N1, a subtype of influenza A, the South Korean government on Tuesday reaffirmed its strong will to prevent the further spread of the illness here.
"We understand many people have fear and anxiety about the rapidly spreading new flu. However, if you believe the government and follow its precautionary rules, there's no need to worry," said Jeon Jae-hee, health, welfare and family affairs minister, reading a statement jointly issued by related ministries and the prime minister's office.
"We have secured enough stockpiles of Tamiflu and Relanza for about 11 per cent of the total population, with a plan to increase the amount to 20 per cent within the year," Jeon said, adding that the antiviral drugs will be available at drug stores across the nation starting Friday.
<TABLE borderColor=#cccccc cellPadding=8 align=right border=0 ?cellspacing="0"><TBODY><TR><TD><SCRIPT type=text/javascript><!-- google_ad_client = "pub-2307967572571578"; /* Inside news 250x250 */ google_ad_slot = "6111004387"; google_ad_width = 250; google_ad_height = 250; //--> </SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type=text/javascript> </SCRIPT><SCRIPT>google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);</SCRIPT></TD></TR></TBODY></TABLE>The announcement came as the nation's death toll from the disease reached 28 with an additional seven deaths newly confirmed Tuesday. The latest cases involve four elderly people in their 70s and 80s, two disabled children and a 26-year-old woman.
The young woman who had no underlying illness died on Monday from viral brain inflammation, a complication of her flu infection. She became the nation's first fatal case among those in their 20s.
"A detailed analysis is underway on the exact cause of her death as the flu virus was found not in the respiratory organs but in the cerebrospinal fluid," said Kwon Jun-wook, senior official at the disease control centre.
"Considering the rapid increase in patients, the number of deaths is also likely to quickly escalate. If you have any suspicious symptoms, you need to be administered with antiviral drugs promptly," Kwon added.
As the domestically-produced vaccine Greenflu-S received final approval from the Korean drug agency last week, the first round of vaccinations yesterday began at medical institutions across the nation.
Starting with healthcare workers in close contact with patients, a total of 17.16 million people included in top priority groups, or 35 per cent of the total population, will be inoculated in several stages by next February.
The next round of vaccinations is scheduled in mid-November at elementary, middle and high schools nationwide.
From early morning, medical staff and other employees at the National Medical Center, in central Seoul, lined up to receive a flu shot. As one of the hospitals specially-designated for the new flu treatment, the hospital has operated 24-hour triage tents, which has recently been visited by 150 patients everyday.
Rubbing her arm, Kim Myung-soon, a nurse's aide at the hospital, said the flu shot made her feel relieved.
"I was somewhat concerned, seeing the long line of crowded patients. Because I'm always in close contact with sick people, I also had been worried about my children at home," she said.
Nearly 750 employees at the hospital are expected to get inoculated against the disease, following the guidelines offered by the Korea Centres for Disease Control and Prevention.
Before receiving a shot, they first fill out a one-page questionnaire about their current health conditions and are briefly examined for possible fever or other flu symptoms. After getting the five-second injection, they are monitored for about 20 minutes for abnormal reactions such as fever, dizziness and lethargy.
"Some doctors who see patients with other illnesses were doubtful about getting the vaccine. Considering a recent surge in patients, however, most of the staff, especially those related to the new flu treatment, are advised to be vaccinated," said Shin Hyung-sik, head of the infectious disease centre, who is responsible for virus treatment and vaccination at the hospital.
"As some reactions were found in those who get vaccinated against the ordinary seasonal influenza, we are closely monitoring suspicious symptoms of vaccine recipients," he added.
"We understand many people have fear and anxiety about the rapidly spreading new flu. However, if you believe the government and follow its precautionary rules, there's no need to worry," said Jeon Jae-hee, health, welfare and family affairs minister, reading a statement jointly issued by related ministries and the prime minister's office.
"We have secured enough stockpiles of Tamiflu and Relanza for about 11 per cent of the total population, with a plan to increase the amount to 20 per cent within the year," Jeon said, adding that the antiviral drugs will be available at drug stores across the nation starting Friday.
<TABLE borderColor=#cccccc cellPadding=8 align=right border=0 ?cellspacing="0"><TBODY><TR><TD><SCRIPT type=text/javascript><!-- google_ad_client = "pub-2307967572571578"; /* Inside news 250x250 */ google_ad_slot = "6111004387"; google_ad_width = 250; google_ad_height = 250; //--> </SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/show_ads.js" type=text/javascript> </SCRIPT><SCRIPT>google_protectAndRun("ads_core.google_render_ad", google_handleError, google_render_ad);</SCRIPT></TD></TR></TBODY></TABLE>The announcement came as the nation's death toll from the disease reached 28 with an additional seven deaths newly confirmed Tuesday. The latest cases involve four elderly people in their 70s and 80s, two disabled children and a 26-year-old woman.
The young woman who had no underlying illness died on Monday from viral brain inflammation, a complication of her flu infection. She became the nation's first fatal case among those in their 20s.
"A detailed analysis is underway on the exact cause of her death as the flu virus was found not in the respiratory organs but in the cerebrospinal fluid," said Kwon Jun-wook, senior official at the disease control centre.
"Considering the rapid increase in patients, the number of deaths is also likely to quickly escalate. If you have any suspicious symptoms, you need to be administered with antiviral drugs promptly," Kwon added.
As the domestically-produced vaccine Greenflu-S received final approval from the Korean drug agency last week, the first round of vaccinations yesterday began at medical institutions across the nation.
Starting with healthcare workers in close contact with patients, a total of 17.16 million people included in top priority groups, or 35 per cent of the total population, will be inoculated in several stages by next February.
The next round of vaccinations is scheduled in mid-November at elementary, middle and high schools nationwide.
From early morning, medical staff and other employees at the National Medical Center, in central Seoul, lined up to receive a flu shot. As one of the hospitals specially-designated for the new flu treatment, the hospital has operated 24-hour triage tents, which has recently been visited by 150 patients everyday.
Rubbing her arm, Kim Myung-soon, a nurse's aide at the hospital, said the flu shot made her feel relieved.
"I was somewhat concerned, seeing the long line of crowded patients. Because I'm always in close contact with sick people, I also had been worried about my children at home," she said.
Nearly 750 employees at the hospital are expected to get inoculated against the disease, following the guidelines offered by the Korea Centres for Disease Control and Prevention.
Before receiving a shot, they first fill out a one-page questionnaire about their current health conditions and are briefly examined for possible fever or other flu symptoms. After getting the five-second injection, they are monitored for about 20 minutes for abnormal reactions such as fever, dizziness and lethargy.
"Some doctors who see patients with other illnesses were doubtful about getting the vaccine. Considering a recent surge in patients, however, most of the staff, especially those related to the new flu treatment, are advised to be vaccinated," said Shin Hyung-sik, head of the infectious disease centre, who is responsible for virus treatment and vaccination at the hospital.
"As some reactions were found in those who get vaccinated against the ordinary seasonal influenza, we are closely monitoring suspicious symptoms of vaccine recipients," he added.
</TD></TR></TBODY></TABLE>
http://www.asianewsnet.net/news.php?id=8415&sec=14
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>
<SCRIPT src="http://googleads.g.doubleclick.net/pagead/test_domain.js"></SCRIPT><SCRIPT src="http://pagead2.googlesyndication.com/pagead/render_ads.js"></SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT><SCRIPT>google_protectAndRun("render_ads.js::google_render_ad", google_handleError, google_render_ad);</SCRIPT>